Jessen Frank,...,Stefanova Elka D,...,(broj koautora 52) (2025) Comment by European Alzheimer's Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer' s disease, JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, vol. 12, br. 8, str. - (Letter) 

Jessen Frank,...,Stefanova Elka D,...,(broj koautora 45) (2024) Progress in the Treatment of Alzheimer's Disease Is Needed - Position Statement of European Alzheimer's Disease Consortium (EADC) Investigators, JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, vol. , br. , str. - (Review; Early Access)